Hillsborough, NC, United States of America

Marc G Caron

This inventor holds 39 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in G Protein-Coupled Receptors. Top assignees: Duke University, Emory University, Molecular Devices Corporation. Active years: 1993-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc G Caron. Retrieved from https://idiyas.com/inventor/marc-g-caron

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 39 

% Patents Active = 84.6


 

Average Co-Inventor Count = 3.9

ph-index = 10

Forward Citations = 395(Granted Patents)


Location History:

  • Durham, GA (US) (1995)
  • La Jolla, CA (US) (2018)
  • Durham, NC (US) (1993 - 2022)
  • Hillsborough, NC (US) (1999 - 2022)

Company Filing History:


Years Active: 1993-2022

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
G Protein-Coupled Receptors
Serotonin Modulation
Cognitive Enhancers
Neurotensin Receptor
Bioavailability
Dopamine Transporter
Small Molecule Agonists
Transgenic Mice
Polymorphism
5-Hydroxytryptophan
Cholinergic Dysfunction
Slow-Release Formulations
39 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Marc G Caron - Pioneering Biochemist from Hillsborough, NC

Introduction:

Marc G Caron, a distinguished biochemist hailing from Hillsborough, NC, has made significant contributions to the field of bioluminescent technologies and pharmaceutical formulations. With an impressive portfolio of 39 patents, Caron continues to revolutionize the way we understand protein interactions and enhance the bioavailability of key compounds.

Latest Patents:

One of Caron's groundbreaking innovations includes the development of the Complex BRET technique for measuring biological interactions. This method allows for the detection of protein interactions in a sample by utilizing polypeptides and dipole acceptor moieties to emit detectable signals in specific light emission spectrums. Additionally, his work on enhancing 5-hydroxytryptophan bioavailability stands out, offering novel methods for increasing the effectiveness of enterally administered 5-HTP through co-administration with low-dose carbidopa.

Career Highlights:

Throughout his career, Caron has been associated with prestigious institutions such as Duke University and Emory University. His expertise and dedication have not only propelled his research forward but have also inspired the next generation of biochemists to push the boundaries of innovation.

Collaborations:

In his pursuit of scientific excellence, Caron has had the privilege of working alongside esteemed colleagues such as Lawrence S Barak and Robert J Lefkowitz. Together, they have shared insights, exchanged ideas, and paved the way for numerous breakthroughs in the realm of bioluminescent complexes and pharmaceutical formulations.

Conclusion:

In conclusion, Marc G Caron's innovative spirit and relentless pursuit of scientific discovery have undoubtedly left an indelible mark on the fields of biochemistry and pharmacology. His patents and research continue to shape the landscape of modern science, offering new possibilities for advancements in healthcare and beyond. Caron's unwavering commitment to innovation serves as a beacon of inspiration for aspiring inventors and researchers worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…